Your browser is no longer supported. Please, upgrade your browser.
Settings
ROSG Rosetta Genomics, Ltd. daily Stock Chart
ROSG [NASD]
Rosetta Genomics, Ltd.
Index- P/E- EPS (ttm)-1.12 Insider Own16.10% Shs Outstand21.95M Perf Week10.28%
Market Cap25.90M Forward P/E- EPS next Y-0.50 Insider Trans0.00% Shs Float20.76M Perf Month-11.28%
Income-17.30M PEG- EPS next Q-0.17 Inst Own10.80% Short Float3.46% Perf Quarter-0.84%
Sales8.30M P/S3.12 EPS this Y11.10% Inst Trans41.99% Short Ratio3.88 Perf Half Y-16.90%
Book/sh0.76 P/B1.55 EPS next Y23.10% ROA- Target Price3.67 Perf Year-68.02%
Cash/sh0.57 P/C2.07 EPS next 5Y15.00% ROE- 52W Range0.71 - 3.97 Perf YTD-4.07%
Dividend- P/FCF- EPS past 5Y52.20% ROI- 52W High-70.28% Beta-3.36
Dividend %- Quick Ratio4.70 Sales past 5Y97.00% Gross Margin24.10% 52W Low66.20% ATR0.10
Employees77 Current Ratio4.70 Sales Q/Q420.00% Oper. Margin- RSI (14)51.24 Volatility10.57% 8.52%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.39 Prev Close1.24
ShortableYes LT Debt/Eq0.00 EarningsMay 19 BMO Payout- Avg Volume185.00K Price1.18
Recom1.80 SMA200.21% SMA50-3.01% SMA200-26.29% Volume73,535 Change-4.84%
Mar-28-16Reiterated Barrington Research Outperform $5 → $3.50
Dec-18-15Initiated Cantor Fitzgerald Buy
Apr-30-15Resumed Barrington Research Outperform
Apr-17-15Upgrade Cantor Fitzgerald Hold → Buy
Oct-30-13Downgrade Aegis Capital Buy → Hold $10 → $3.50
May-26-16 07:00AM  Rosetta Genomics Announces Publication of Data Confirming Analytical Validity of its Novel Thyroid Nodule Classification Assay Business Wire +9.73%
May-23-16 08:00AM  Rosetta Genomics Receives Approval from New York State for Four PCR-Based Assays Business Wire
May-19-16 03:41PM  Edited Transcript of ROSG earnings conference call or presentation 19-May-16 2:00pm GMT -13.11%
08:00AM  Rosetta Genomics Reports 2016 First Quarter Financial Results Business Wire
07:07AM  Q1 2016 Rosetta Genomics Ltd Earnings Release - Before Market Open
May-16-16 08:00AM  Rosetta Genomics to Host 2016 First Quarter Financial Results and Business Update Conference Call on May 19, 2016 Business Wire
Apr-13-16 09:35AM  Rosetta Genomics Ltd. :ROSG-US: Earnings Analysis: Q4, 2015 By the Numbers
09:01AM  Rosetta Genomics Ltd. :ROSG-US: Earnings Analysis: 2015 By the Numbers
Mar-29-16 01:04PM  ROSETTA GENOMICS LTD. Financials -7.50%
Mar-28-16 03:15PM  ROSG: Revenue Growth Accelerated in 4Q15
Mar-23-16 04:26PM  Rosetta Genomics Reports 2015 Full Year Financial Results at noodls
04:05PM  Rosetta Genomics Reports 2015 Full Year Financial Results Business Wire
07:07AM  Full Year 2015 Rosetta Genomics Ltd Earnings Release - Time Not Supplied
Mar-17-16 08:30AM  Rosetta Genomics to Host Business Update and 2015 Year-End Financial Results Conference Call on March 23, 2016 Business Wire
Feb-29-16 09:00AM  Rosetta Genomics Appoints Ana C. Ward as Executive Vice President, Legal and Corporate Development Business Wire
Feb-25-16 09:00AM  Rosetta Genomics Expands Molecular Diagnostics Test Menu with Launch of Three New Product Offerings Business Wire
Feb-18-16 09:00AM  Rosetta Genomics Receives Approval from New York State for First-of-its-kind Thyroid Cancer Diagnostic Assay Business Wire +19.15%
Feb-08-16 08:00AM  Rosetta Genomics to Present at Source Capital's 2016 Disruptive Growth & Healthcare Conference Business Wire
Feb-01-16 02:22PM  Rosetta Genomics Announces Agreement with Americas Choice Provider Network for Entire Suite of Diagnostic Tests and Services at noodls
08:00AM  Rosetta Genomics Announces Agreement with Americas Choice Provider Network for Entire Suite of Diagnostic Tests and Services Business Wire
Jan-25-16 02:27PM  Rosetta Genomics Granted U.S. Patent Allowance for Use of Gene Expression Signature for Classification of Kidney Tumors at noodls +8.43%
08:00AM  Rosetta Genomics Granted U.S. Patent Allowance for Use of Gene Expression Signature for Classification of Kidney Tumors Business Wire
Jan-11-16 10:19AM  CORRECTING and REPLACING Rosetta Genomics Granted EPO Patent Allowance for Use of microRNA Molecules for the Treatment of Liver Cancer Business Wire
Jan-06-16 08:00AM  Rosetta Genomics Grants Sublicenses to Mirna Therapeutics for microRNA-related Patents for the Development of Oncology Therapeutics Business Wire -5.04%
Dec-18-15 04:16PM  Rosetta Genomics (ROSG) Stock Closed Up on Cantor Fitzgerald Rating at TheStreet
10:47AM  4 Stocks Under $10 Showing Great Upside Today Accesswire
06:44AM  4 Biotech Stocks Under $10 Poised for Big Breakouts at TheStreet
05:50AM  Coverage initiated on Rosetta Genomics by Cantor Fitzgerald
Dec-14-15 08:00AM  Rosetta Genomics and Biocept Advance Collaboration to Proof-of-Concept Studies Aimed at microRNA Profiling of Circulating Tumor Cells to Enhance Lung Cancer Diagnosis Business Wire
Dec-02-15 02:00PM  ROSG Reports Record Revenue for Third Quarter 2015 -11.03%
Dec-01-15 08:00AM  Rosetta Genomics Reports Third Quarter 2015 Financial Results Business Wire
Nov-24-15 08:30AM  Rosetta Genomics to Present at the LD Micro Main Event Accesswire -8.98%
Nov-12-15 08:58AM  Rosetta Provides Update on Performance Data and Launch of RosettaGX Reveal (Thyroid microRNA Classifier) Business Wire
Nov-04-15 08:30AM  Rosetta Genomics Appoints Dr. Maria Fe Paz as Interim Chief Medical Officer Business Wire
Oct-27-15 04:15PM  ROSG: Rosetta Reports Strong Revenue Growth for 1H15
Oct-26-15 05:19PM  Rosetta Genomics Reports Financial Results for the First Half of 2015 Business Wire
Oct-21-15 09:20AM  Positive Performance Data from Validation Study of Rosetta Genomics microRNA-based Diagnostic Assay for Thyroid Nodule Classification Presented at the International Thyroid Congress and Annual Meeting of the American Thyroid Association Business Wire
Oct-20-15 08:30AM  Rosetta Genomics to Host Business Update and Six Month Financials Conference Call on October 27, 2015 Business Wire
Oct-14-15 07:00AM  Rosetta Genomics Raises $8,000,000 in Private Placement Business Wire -8.63%
Oct-12-15 08:30AM  Rosetta Genomics Launches BRAF Mutation Assay Business Wire
Oct-01-15 08:30AM  Rosetta Genomics to Present at 2015 Aegis Growth Conference Business Wire
Sep-30-15 09:15AM  Rosetta Genomics to Partner with FNApath to Provide Centralized Laboratory Testing Services for Thyroid Cancer GlobeNewswire
Sep-22-15 08:57AM  Rosetta Genomics Receives U.S. Patent for Treatment of Prostate Cancer Business Wire
Sep-08-15 03:30PM  CORRECTING and REPLACING Rosetta Genomics to Present at the 17th Annual Rodman & Renshaw Global Investment Conference Business Wire +6.10%
Sep-04-15 10:34AM  Rosetta Genomics to Present at the 17th Annual Rodman & Renshaw Global Investment Conference Business Wire
Aug-06-15 09:00AM  Rosetta Genomics Receives Conditional Approval from New York State for Lung Biomarker Business Wire
08:00AM  Rosetta Genomics Receives Accreditation from College of American Pathologists for its Laboratory in California Business Wire
Jul-28-15 08:00AM  Rosetta Genomics Expands High-Value Molecular Diagnostic Offering with Launch of OncoGxSelect Business Wire
Jul-09-15 04:30PM  ROSG: Strong Revenue Growth Expected for 1H15 and the Full Year 2015
Jul-08-15 05:38PM  Rosetta Genomics Files Pro Forma Financials in Connection with PersonalizeDx Acquisition Business Wire
Jul-01-15 08:00AM  Rosetta Genomics Announces Participation in Cantor Fitzgeralds Inaugural From Bench to Bedside Healthcare Conference Business Wire
Jun-16-15 08:30AM  Rosetta Genomics Announces Agreement with MultiPlan for its PersonalizeDx Suite of Testing Services Business Wire
Jun-01-15 11:17AM  US Military Accidentally Ships Live Anthrax via FedEx; These Are the Stocks to Watch in Its Wake Accesswire
May-28-15 09:06AM  Rosetta Genomics Launches OncoGxOne Business Wire
May-26-15 09:00AM  Rosetta Genomics Announces Selection of First Pilot Project Grant under Strategic Alliance with Moffitt Cancer Center Business Wire
May-14-15 08:48AM  Rosetta Genomics Launches Two Assays for Bladder Cancer Business Wire
May-13-15 09:07AM  Rosetta Genomics Receives Additional U.S. Patent Protection for the Cancer Origin Test Business Wire
May-12-15 08:23AM  Data on Rosetta Genomics Novel Thyroid Nodule Classification Assay to be Presented at the American Association of Clinical Endocrinologists 24th Annual Scientific and Clinical Congress Business Wire
May-06-15 09:49AM  The Earnings Season: Complementary Research on Rosetta Genomics, Alder Biopharmaceuticals, TASER International, GrafTech, and Rockwell Automation at noodls
Apr-29-15 09:01AM  Rosetta Genomics Patent on Therapeutic Use of miR-34a Upheld by European Patent Office in Opposition Proceedings at noodls
08:56AM  Rosetta Genomics Patent on Therapeutic Use of miR-34a Upheld by European Patent Office in Opposition Proceedings Business Wire
Apr-20-15 08:58AM  Rosetta Genomics Announces Data Published in Leukemia Research at noodls +6.63%
08:30AM  Rosetta Genomics Announces Data Published in Leukemia Research Business Wire
Apr-17-15 12:56PM  Rosseta Genomics (ROSG) Stock Continues To Climb Today on Analyst Upgrade at TheStreet
09:42AM  Rosetta Genomics Shares Upgraded At Cantor
Apr-16-15 10:54AM  Rosetta Genomics (ROSG) Stock is Spiking on Receipt of Cancer Origin Test Patent at TheStreet
09:35AM  Rosetta Genomics Receives Key U.S. Patent Allowance for its Cancer of Origin Diagnostic Assay at noodls
09:15AM  Rosetta Genomics Receives Key U.S. Patent Allowance for its Cancer of Origin Diagnostic Assay Business Wire
Apr-15-15 02:25PM  ROSG: Acquisition of PersonalizeDx Will Accelerate Substantial Revenue Growth +14.20%
Apr-14-15 08:44AM  Rosetta Genomics Completes Acquisition of PersonalizeDx at noodls
08:30AM  Rosetta Genomics Completes Acquisition of PersonalizeDx Business Wire
Apr-09-15 12:24PM  Rosetta Genomics to Acquire PersonalizeDx at noodls +11.86%
12:16PM  Rosetta Genomics to Acquire PersonalizeDx Business Wire
Mar-26-15 08:48AM  Rosetta Genomics Receives Key U.S. Patent Allowance for its Novel Kidney Cancer Test at noodls +8.16%
08:30AM  Rosetta Genomics Receives Key U.S. Patent Allowance for its Novel Kidney Cancer Test Business Wire
Mar-25-15 08:14AM  Rosetta Genomics to Launch Next-Generation Sequencing Panel from Admera Health at noodls
08:00AM  Rosetta Genomics to Launch Next-Generation Sequencing Panel from Admera Health Business Wire
Mar-18-15 09:00AM  ROSG Reports Record Revenue for 2014 -5.30%
Mar-16-15 04:34PM  Rosetta Genomics Reports 2014 Financial Results at noodls
04:30PM  Rosetta Genomics Reports 2014 Financial Results Business Wire
07:07AM  Q4 2014 Rosetta Genomics Ltd Earnings Release - 10:00 am ET
Mar-10-15 01:06PM  Rosetta Genomics to Host Business Update and 2014 Year End Financials Conference Call on March 17, 2015 at noodls
12:31PM  Rosetta Genomics to Host Business Update and 2014 Year End Financials Conference Call on March 17, 2015 Business Wire
Mar-04-15 09:07AM  Rosetta Genomics to Present at the 27th Annual ROTH Conference at noodls
08:31AM  Rosetta Genomics to Present at the 27th Annual ROTH Conference Business Wire
Feb-26-15 01:19PM  Rosetta Genomics Novel and Differentiated Thyroid Cancer Assay Moves to Advanced Stages of Development at noodls
08:25AM  Rosetta Genomics Novel and Differentiated Thyroid Cancer Assay Moves to Advanced Stages of Development Business Wire
Feb-20-15 09:00AM  ROSG: Broad Patent Allowances Assure Sustainable Growth
Feb-18-15 10:33AM  Rosetta Genomics (ROSG) Stock Sells Off Today Following Tuesday's Surge at TheStreet -20.83%
Feb-17-15 02:56PM  One ETF Gets a Lift From Rosetta Genomics ETF Trends +31.51%
11:35AM  Rosetta Genomics (ROSG) Stock Soars Today After Patent Allowance Announcements at TheStreet
08:15AM  Rosetta Genomics Announces Key Patent Allowances in U.S. and Europe Business Wire
Feb-10-15 08:41AM  Rosetta Genomics Receives First Patent Allowance in Japan Business Wire
Feb-09-15 08:00AM  Rosetta Genomics Announces Commercial Partnership with Precipio Diagnostics Business Wire
Jan-20-15 08:00AM  Clinician Survey Supporting Value Proposition of the Rosetta Kidney Cancer Test Published in the Journal of Kidney Cancer Business Wire
Jan-12-15 08:00AM  Rosetta Genomics Issues Letter to Shareholders Business Wire
Jan-08-15 08:00AM  Rosetta Genomics Announces Launch of Admera Healths Sequencing-Based Oncology Tests Business Wire +7.78%
Nov-25-14 08:00AM  Rosetta Genomics to Present at LD MICRO Main Event Micro-Cap Growth Conference on December 3, 2014 Business Wire
Nov-18-14 08:00AM  Rosetta Genomics and Marina Biotech Initiate First Clinical Project Under Strategic Alliance Marketwired
Nov-04-14 08:38AM  Rosetta Genomics Announces Publication of Data Demonstrating Differentiation of Adrenocortical Carcinomas from Adenomas by microRNA Profiling Business Wire
Rosetta Genomics Ltd. develops and commercializes microRNA-based and other molecular diagnostics. MicroRNAs are a group of genes that are produced using instructions encoded in DNA. The company offers diagnostic tests, including RosettaGX Cancer Origin, a diagnostic for the identification of metastatic cancer; mi-LUNG, a lung cancer classification test for cytology samples; mi-KIDNEY, a kidney tumor classification test for pathology samples; and RosettaGX Reveal, a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate (FNA) samples. It is also developing RosettaGX Reveal V2, a microRNA-based assay for the diagnosis of indeterminate thyroid FNAs; and tissue-based microRNA biomarkers to develop a test for the risk stratification of patients with non-muscle-invasive bladder cancer. The company distributes its products primarily in Australia, Canada, Greece, India, Israel, New Zealand, Qatar, Romania, Saudi Arabia, Singapore, Turkey, and the United Arab Emirates. Rosetta Genomics Ltd. was founded in 2000 and is based in Rehovot, Israel.